Vertex Pharmaceuticals News

Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse

marketbeat.com · Jul 11, 2026

Is This Biotech Stock a Buy Near Its 52-Week High?

fool.com · Jul 10, 2026

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?

fool.com · Jul 10, 2026

Why Crinetics Stock Soared 99% This Week

247wallst.com · Jul 9, 2026

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

247wallst.com · Jul 9, 2026

Nvidia, Vertex Pharmaceuticals And More On CNBC's ‘Final Trades'

benzinga.com · Jul 9, 2026

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

businesswire.com · Jul 8, 2026

Vertex's Crinetics Deal Balances Growth with Integration Risk

marketbeat.com · Jul 8, 2026

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

fool.com · Jul 8, 2026

Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know.

fool.com · Jul 7, 2026

Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note

zacks.com · Jul 7, 2026

Vertex to Announce Second Quarter 2026 Financial Results on August 3rd

businesswire.com · Jul 7, 2026

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

247wallst.com · Jul 7, 2026

Crinetics shares surge after Vertex agrees to $10B cash buyout

invezz.com · Jul 7, 2026

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)

newsfilecorp.com · Jul 7, 2026

Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets

benzinga.com · Jul 7, 2026

Breakfast News: Vertex Bets $10B to Win $5B a Year

fool.com · Jul 7, 2026

Why Crinetics Pharmaceuticals Shares Are Trading Higher By 99%; Here Are 20 Stocks Moving Premarket

benzinga.com · Jul 7, 2026

Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript

seekingalpha.com · Jul 7, 2026

Vertex Pharma Makes A $10 Billion Deal; Biotech Stock Doubles

investors.com · Jul 6, 2026

Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why

benzinga.com · Jul 6, 2026

Vertex to buy Crinetics in $10 billion deal

reuters.com · Jul 6, 2026

Vertex to Acquire Crinetics Pharmaceuticals

businesswire.com · Jul 6, 2026

Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?

fool.com · Jul 6, 2026

While SpaceX Gets the Headlines, Smart Investors Are Loading Up on This Stock Instead

fool.com · Jul 5, 2026

Wall Street Bulls Look Optimistic About Vertex (VRTX): Should You Buy?

zacks.com · Jul 3, 2026

Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?

fool.com · Jul 3, 2026

Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT

zacks.com · Jul 2, 2026

Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia

businesswire.com · Jul 1, 2026

US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two

reuters.com · Jul 1, 2026

Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?

fool.com · Jul 1, 2026

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

zacks.com · Jul 1, 2026

Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech

seekingalpha.com · Jun 30, 2026

CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jun 27, 2026

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

zacks.com · Jun 26, 2026

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

zacks.com · Jun 24, 2026

Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade)

seekingalpha.com · Jun 24, 2026

Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.

fool.com · Jun 20, 2026

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why

zacks.com · Jun 18, 2026

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

zacks.com · Jun 17, 2026

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

zacks.com · Jun 17, 2026

The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex

247wallst.com · Jun 12, 2026

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

zacks.com · Jun 11, 2026

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

etftrends.com · Jun 11, 2026

Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions

businesswire.com · Jun 11, 2026

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

zacks.com · Jun 10, 2026

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com · Jun 10, 2026

Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?

fool.com · Jun 8, 2026

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference

businesswire.com · Jun 5, 2026

Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?

fool.com · Jun 4, 2026

Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue?

zacks.com · Jun 3, 2026

FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy

zacks.com · Jun 2, 2026

Got $5,000? 1 Cash-Flow King to Buy and Hold Forever That Wall Street Is Completely Mispricing

247wallst.com · Jun 2, 2026

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

zacks.com · Jun 1, 2026

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

businesswire.com · Jun 1, 2026

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

seekingalpha.com · May 29, 2026

These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth

247wallst.com · May 28, 2026

Vertex Pharmaceuticals Incorporated (VRTX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

seekingalpha.com · May 19, 2026

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

zacks.com · May 19, 2026

VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings

zacks.com · May 8, 2026